FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 2151407 · Received July 6, 2011

Report

Report Number
2124215-2011-07134
Event Type
Injury
Date Received
July 6, 2011
Date of Event
April 5, 2011
Report Date
March 19, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

SUBSEQUENT INFORMATION FROM THE LOCAL FIELD REPRESENTATIVE INDICATED THAT THE PATIENT WILL CONTINUE TO BE MONITORED FOR NOW. THERE WERE NO ADVERSE PATIENT EFFECTS REPORTED. IF ADDITIONAL INFORMATION BECOMES AVAILABLE, THIS REPORT WILL BE UPDATED.

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Additional Manufacturer Narrative · 1

AS OF TODAY, THERE IS NO ADDITIONAL INFORMATION AVAILABLE AND OUR INVESTIGATION IS COMPLETE. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS REPORT WILL BE

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT VENTRICULAR (RV) LEAD DISPLAYED A HIGH, OUT OF RANGE PACE IMPEDANCE MEASUREMENT. THERE WERE NO ADVERSE PATIENT EFFECTS WERE REPORTED. A REQUEST FOR ADDITIONAL INFORMATION HAS BEE MADE. THE LEAD REMAINS IN SERVICE.

Description of Event or Problem · 1

SUBSEQUENT INFORMATION INDICATED THAT THE PATIENT UNDERWENT A LEAD REVISION PROCEDURE WHERE THE LEAD WAS SURGICALLY ABANDONED AND REPLACED. THERE WERE NO ADVERSE PATIENT EFFECTS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0147

Patients

Seq Age Sex Outcome Treatment
1 61 YR Hospitalization| L| R E102| 0147